A Case Report: The Myxomatous Mystery by Kim, Joseph et al.
Case Report: The Myxomatous Mystery
Joseph S. Kim, BS[1], Nicole P. Pantle, MS[1], and Jacquelyn E. Fisher, DO[2]
[1] Philadelphia College of Osteopathic Medicine, Philadelphia, PA
[2] Internal Medicine, Paoli Hospital, Main Line Health, Paoli, PA
Introduction
Primary cardiac tumors are rare with an incidence rate of 
1.38 new cases per 100,000 individuals per year. Of these 
tumors, 75% are benign in origin and the most common 
type is a myxoma with a frequency of over 50%. Myxomas
most commonly arise from the left atrium followed by the 
right atrium. Clinical presentation of a myxoma varies 
depending on the location, size, and shape of the tumor. 
For example, a patient diagnosed with a myxoma may have 
constitutional symptoms, cardiovascular symptoms, 
pulmonary symptoms, etc., or may be entirely 
asymptomatic. Since there are no specific symptoms 
presented by patients with a myxoma, physicians often face 







A 72-year-old female with a past medical history of 
hypertension presented to the Emergency Department (ED) 
with progressive dyspnea on exertion of 1-week duration. 
She reported chest tightness, orthopnea, and paroxysmal 
nocturnal dyspnea. She denied experiencing similar 
symptoms in the past. Vital signs were unremarkable 
except for her blood pressure which was 178/103 mm Hg. 
Pertinent physical exam findings included jugular venous 
distension, a S3 heart sound, and bibasilar rales. 
Laboratory tests were ordered and all were unremarkable, 
including her troponin I and BNP levels. ECG was 
significant for T wave inversion in the inferior leads. Chest 
x-ray and CT were ordered and showed diffuse ground 
glass opacities throughout both lungs, bilateral pleural 
effusions, and mild cardiomegaly, as well as dilation of the 
main pulmonary artery. Lasix was given as patient 
appeared to be volume overloaded, which resulted in brisk 
diuresis and relief of symptoms. At this point, an acute 
exacerbation of left-sided heart failure was suspected and a 
transthoracic echocardiogram (TTE) was ordered. TTE 
revealed a large ovoid mobile echodense mass. The mass 
was 5.1 cm x 2.9 cm and attached to the lower half of the 
interatrial septum on the left atrium and moved in and out of 
the left ventricular inflow. This finding was most consistent 
with a left atrial myxoma and the patient was then 
transferred to a medical center capable of resecting the 
myxoma. The patient tolerated the myxoma excision well 
and was discharged to cardiac rehabilitation. The surgical 
pathology report confirmed cardiac myxoma with central 
hemorrhage.
In the setting of predisposed hypertension, we suspect that the large size and 
mobile nature of the left atrial myxoma caused functional partial obstruction of 
the mitral valve, leading to secondary valvular heart disease. Our patient had 
normal BNP levels on presentation, and on TTE, had normal left atrial and
ventricular sizes, a normal left ventricular ejection fraction of 60-65%, and only 
mild mitral regurgitation. However, the obstruction of the mitral valve was 
significant enough to raise pulmonary artery pressure to 38 mm Hg and cause 
progressive left-sided heart failure symptoms; the patient was presenting with 
both dyspnea on exertion and bilateral pleural effusions. The presence of 
mildly reduced right ventricular systolic function and mild tricuspid regurgitation 
suggests that right ventricular remodeling would have been inevitable in our 
patient if the myxoma remained untreated.
In a systematic review of 112 cases of left atrial myxomas, symptoms of mitral 
valve obstruction, the first arm of the classic triad of myxoma presentation, 
were present in 75 patients (67%), with mostly cardiac failure or malaise. 
Symptoms of embolism, the second most frequent presentation in the classic 
triad, were observed in 33 cases (29%). The third arm of the classic triad 
consisted of constitutional symptoms (34%) with fever, weight loss, or 
symptoms resembling connective tissue disease, due to cytokine secretion. 
The most frequent electrocardiographic sign discovered was left atrial 
hypertrophy (35%), whereas arrhythmias were uncommon. A review of 
laboratory data also suggested anemia and an elevated ESR, CRP, or globulin 
level could be present. Our patient displayed symptoms of mitral valve 
obstruction and mild cardiomegaly with unremarkable bloodwork, prompting 
the team to explore a diagnosis of acute heart failure originally. The long-term 
prognosis of left atrial myxomas is excellent and the recurrence rate is low. 
Long-term follow-up and serial echocardiography are advisable especially for 
young patients, and this was the recommendation for our patient as well.
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Despite the rarity of the disease, myxomas, as well as other cardiac 
tumors, should always be included in the differential diagnosis when a 
patient presents with symptoms suspected of an acute exacerbation of 
heart failure. Echocardiogram is the diagnostic modality of choice to 
utilize when a myxoma is suspected. Once the diagnosis is confirmed, 
myxomas must be surgically resected in a timely manner in order to 
prevent complications of systemic embolization and other 
cardiovascular diseases, which may lead to sudden death.
